Bayer has snapped up certain licensing rights from ProStrakan to develop and market the Scotland-based speciality pharmaceuticals group’s testosterone replacement gel Tostran in 65 countries. Bayer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback